Targeting COL5A1 enhances anoikis thus attenuating malignancy of glioblastoma via inhibiting the Wnt/β-catenin signaling pathway
Open Access
- 22 May 2025
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 174 (1) , 97-109
Abstract
Purpose As one of the most prevalent primary brain tumors, glioblastoma (GBM) is characterized by its severe malignancy and extremely poor prognosis. Recent studies have demonstrated that targeting anoikis and malignancy showed impressed efficiency for treatment in a wide range of solid tumors, however, relevant research on GBM still remains unclarified. Methods In this study, genes related with malignancy and anoikis of GBM were identified by utilizing the Cancer Genome Atlas (TCGA), the Chinese Glioma Genome Atlas (CGGA) and the Molecular Signatures Database (MSigDB). Subsequently, the role of the key gene was validated via proliferation, invasion and migration experiments both in conditions with and without attachment. Moreover, RNA sequencing analysis was employed to reveal further mechanisms. Results Here, Type V collagen alpha 1 (COL5A1) was identified as a critical gene associated with anoikis and poor outcomes. Additionally, COL5A1 knockdown induced significant reduction in malignancy of GBM both in vitro and in vivo. Moreover, cell anoikis was remarkable enhanced by reduced expression of COL5A1 after low-attachment cell culture. Mechanically, RNA sequencing analysis revealed that the activity of the Wnt/β-catenin signaling pathway was diminished following COL5A1 knockdown, which indicated that COL5A1 reduced anoikis via regulating Wnt/β-catenin signaling pathway thus promoted malignancies of GBM cells. Conclusion These findings demonstrated the novel evidence that COL5A1 serves as an essential regulatory factor influencing both anoikis and malignancy of GBM cells by regulating Wnt/β-catenin signaling pathway, indicating that COL5A1 could be a novel prognosis-related biomarker and potential therapeutic target for GBM.Keywords
Funding Information
- Natural Science Basic Research Program of Shaanxi Province (KS2024-JC-QN-1021, 2021JM-271)
- National Natural Science Foundation of China (82173285, 82173285)
- Innovation Capacity Support Plan of Shaanxi Province (2024ZC-KJXX-091)
This publication has 46 references indexed in Scilit:
- Targeting TUBB3 Suppresses Anoikis Resistance and Bone Metastasis in Prostate CancerAdvanced Healthcare Materials, 2024
- Glioblastoma and Other Primary Brain Malignancies in AdultsJAMA, 2023
- World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type GliomasJAMA Oncology, 2022
- Metastasis associated long noncoding RNAs in glioblastoma: Biomarkers and therapeutic targetsJournal of Cellular Physiology, 2021
- Overexpressed COL5A1 is correlated with tumor progression, paclitaxel resistance, and tumor‐infiltrating immune cells in ovarian cancerJournal of Cellular Physiology, 2021
- LncRNA HOTAIR promotes the growth and metastasis of gastric cancer by sponging miR-1277-5p and upregulating COL5A1Gastric Cancer, 2020
- The FZD7‐TWIST1 axis is responsible for anoikis resistance and tumorigenesis in ovarian carcinomaMolecular Oncology, 2018
- DIDS inhibits overexpression BAK1‐induced mitochondrial apoptosis through GSK3β/β‐catenin signaling pathwayJournal of Cellular Physiology, 2018
- Glioblastoma and Other Malignant GliomasJAMA, 2013
- Anoikis: an emerging hallmark in health and diseasesThe Journal of Pathology, 2011